 | • レポートコード：MRC2-11QY12639 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は黒色腫がんのグローバル市場について調査・分析したレポートです。種類別（非浸潤性黒色腫、浸潤性黒色腫）市場規模、用途別（病院、がん研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別黒色腫がんの競争状況、市場シェア ・世界の黒色腫がん市場：種類別市場規模 2015年-2020年（非浸潤性黒色腫、浸潤性黒色腫） ・世界の黒色腫がん市場：種類別市場規模予測 2021年-2026年（非浸潤性黒色腫、浸潤性黒色腫） ・世界の黒色腫がん市場：用途別市場規模 2015年-2020年（病院、がん研究センター） ・世界の黒色腫がん市場：用途別市場規模予測 2021年-2026年（病院、がん研究センター） ・北米の黒色腫がん市場分析：米国、カナダ ・ヨーロッパの黒色腫がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの黒色腫がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の黒色腫がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの黒色腫がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AB Sciences、Incyte、Merck、Novartis、Pierre Fabre、Amgen、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Melanoma Cancer is a skin cancer that develops due to expose of UV rays on the skin.
Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the major factors that are driving the market during the forecast period. Additionally, overexposure to radiation during certain treatments or exposure to chemicals during working, increasing awareness about cancer, and rising healthcare expenditure is also motivating the market.
Market Analysis and Insights: Global Melanoma Cancer Market
The global Melanoma Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Melanoma Cancer Scope and Market Size
Melanoma Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
Market segment by Type, the product can be split into
Non-invasive melanoma
Invasive melanoma
Market segment by Application, split into
Hospitals
Cancer Research Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Melanoma Cancer Revenue
1.4 Market by Type
1.4.1 Global Melanoma Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non-invasive melanoma
1.4.3 Invasive melanoma
1.5 Market by Application
1.5.1 Global Melanoma Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Cancer Market Perspective (2015-2026)
2.2 Global Melanoma Cancer Growth Trends by Regions
2.2.1 Melanoma Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Melanoma Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Melanoma Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Melanoma Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Melanoma Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Cancer Players by Market Size
3.1.1 Global Top Melanoma Cancer Players by Revenue (2015-2020)
3.1.2 Global Melanoma Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Melanoma Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Melanoma Cancer Market Concentration Ratio
3.2.1 Global Melanoma Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Revenue in 2019
3.3 Melanoma Cancer Key Players Head office and Area Served
3.4 Key Players Melanoma Cancer Product Solution and Service
3.5 Date of Enter into Melanoma Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Melanoma Cancer Historic Market Size by Type (2015-2020)
4.2 Global Melanoma Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Melanoma Cancer Market Size by Application (2015-2020)
5.2 Global Melanoma Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Melanoma Cancer Market Size (2015-2020)
6.2 Melanoma Cancer Key Players in North America (2019-2020)
6.3 North America Melanoma Cancer Market Size by Type (2015-2020)
6.4 North America Melanoma Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Melanoma Cancer Market Size (2015-2020)
7.2 Melanoma Cancer Key Players in Europe (2019-2020)
7.3 Europe Melanoma Cancer Market Size by Type (2015-2020)
7.4 Europe Melanoma Cancer Market Size by Application (2015-2020)
8 China
8.1 China Melanoma Cancer Market Size (2015-2020)
8.2 Melanoma Cancer Key Players in China (2019-2020)
8.3 China Melanoma Cancer Market Size by Type (2015-2020)
8.4 China Melanoma Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Melanoma Cancer Market Size (2015-2020)
9.2 Melanoma Cancer Key Players in Japan (2019-2020)
9.3 Japan Melanoma Cancer Market Size by Type (2015-2020)
9.4 Japan Melanoma Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Melanoma Cancer Market Size (2015-2020)
10.2 Melanoma Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Melanoma Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Melanoma Cancer Market Size by Application (2015-2020)
11 India
11.1 India Melanoma Cancer Market Size (2015-2020)
11.2 Melanoma Cancer Key Players in India (2019-2020)
11.3 India Melanoma Cancer Market Size by Type (2015-2020)
11.4 India Melanoma Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Melanoma Cancer Market Size (2015-2020)
12.2 Melanoma Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Melanoma Cancer Market Size by Type (2015-2020)
12.4 Central & South America Melanoma Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AB Sciences
13.1.1 AB Sciences Company Details
13.1.2 AB Sciences Business Overview
13.1.3 AB Sciences Melanoma Cancer Introduction
13.1.4 AB Sciences Revenue in Melanoma Cancer Business (2015-2020))
13.1.5 AB Sciences Recent Development
13.2 Incyte
13.2.1 Incyte Company Details
13.2.2 Incyte Business Overview
13.2.3 Incyte Melanoma Cancer Introduction
13.2.4 Incyte Revenue in Melanoma Cancer Business (2015-2020)
13.2.5 Incyte Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Melanoma Cancer Introduction
13.3.4 Merck Revenue in Melanoma Cancer Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Melanoma Cancer Introduction
13.4.4 Novartis Revenue in Melanoma Cancer Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Pierre Fabre
13.5.1 Pierre Fabre Company Details
13.5.2 Pierre Fabre Business Overview
13.5.3 Pierre Fabre Melanoma Cancer Introduction
13.5.4 Pierre Fabre Revenue in Melanoma Cancer Business (2015-2020)
13.5.5 Pierre Fabre Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Melanoma Cancer Introduction
13.6.4 Amgen Revenue in Melanoma Cancer Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Melanoma Cancer Introduction
13.7.4 AstraZeneca Revenue in Melanoma Cancer Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Details
13.8.2 Bristol-Myers Squibb Business Overview
13.8.3 Bristol-Myers Squibb Melanoma Cancer Introduction
13.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2015-2020)
13.8.5 Bristol-Myers Squibb Recent Development
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Details
13.9.2 Daiichi Sankyo Business Overview
13.9.3 Daiichi Sankyo Melanoma Cancer Introduction
13.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Business (2015-2020)
13.9.5 Daiichi Sankyo Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Melanoma Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Melanoma Cancer Revenue
Table 3. Ranking of Global Top Melanoma Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Melanoma Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non-invasive melanoma
Table 6. Key Players of Invasive melanoma
Table 7. Global Melanoma Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Melanoma Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Melanoma Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Melanoma Cancer Market Share by Regions (2015-2020)
Table 11. Global Melanoma Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Melanoma Cancer Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Melanoma Cancer Market Growth Strategy
Table 17. Main Points Interviewed from Key Melanoma Cancer Players
Table 18. Global Melanoma Cancer Revenue by Players (2015-2020) (Million US$)
Table 19. Global Melanoma Cancer Market Share by Players (2015-2020)
Table 20. Global Top Melanoma Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Cancer as of 2019)
Table 21. Global Melanoma Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Melanoma Cancer Product Solution and Service
Table 24. Date of Enter into Melanoma Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Melanoma Cancer Market Size by Type (2015-2020) (Million US$)
Table 27. Global Melanoma Cancer Market Size Share by Type (2015-2020)
Table 28. Global Melanoma Cancer Revenue Market Share by Type (2021-2026)
Table 29. Global Melanoma Cancer Market Size Share by Application (2015-2020)
Table 30. Global Melanoma Cancer Market Size by Application (2015-2020) (Million US$)
Table 31. Global Melanoma Cancer Market Size Share by Application (2021-2026)
Table 32. North America Key Players Melanoma Cancer Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Melanoma Cancer Market Share (2019-2020)
Table 34. North America Melanoma Cancer Market Size by Type (2015-2020) (Million US$)
Table 35. North America Melanoma Cancer Market Share by Type (2015-2020)
Table 36. North America Melanoma Cancer Market Size by Application (2015-2020) (Million US$)
Table 37. North America Melanoma Cancer Market Share by Application (2015-2020)
Table 38. Europe Key Players Melanoma Cancer Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Melanoma Cancer Market Share (2019-2020)
Table 40. Europe Melanoma Cancer Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Melanoma Cancer Market Share by Type (2015-2020)
Table 42. Europe Melanoma Cancer Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Melanoma Cancer Market Share by Application (2015-2020)
Table 44. China Key Players Melanoma Cancer Revenue (2019-2020) (Million US$)
Table 45. China Key Players Melanoma Cancer Market Share (2019-2020)
Table 46. China Melanoma Cancer Market Size by Type (2015-2020) (Million US$)
Table 47. China Melanoma Cancer Market Share by Type (2015-2020)
Table 48. China Melanoma Cancer Market Size by Application (2015-2020) (Million US$)
Table 49. China Melanoma Cancer Market Share by Application (2015-2020)
Table 50. Japan Key Players Melanoma Cancer Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Melanoma Cancer Market Share (2019-2020)
Table 52. Japan Melanoma Cancer Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Melanoma Cancer Market Share by Type (2015-2020)
Table 54. Japan Melanoma Cancer Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Melanoma Cancer Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Melanoma Cancer Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Melanoma Cancer Market Share (2019-2020)
Table 58. Southeast Asia Melanoma Cancer Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Melanoma Cancer Market Share by Type (2015-2020)
Table 60. Southeast Asia Melanoma Cancer Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Melanoma Cancer Market Share by Application (2015-2020)
Table 62. India Key Players Melanoma Cancer Revenue (2019-2020) (Million US$)
Table 63. India Key Players Melanoma Cancer Market Share (2019-2020)
Table 64. India Melanoma Cancer Market Size by Type (2015-2020) (Million US$)
Table 65. India Melanoma Cancer Market Share by Type (2015-2020)
Table 66. India Melanoma Cancer Market Size by Application (2015-2020) (Million US$)
Table 67. India Melanoma Cancer Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Melanoma Cancer Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Melanoma Cancer Market Share (2019-2020)
Table 70. Central & South America Melanoma Cancer Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Melanoma Cancer Market Share by Type (2015-2020)
Table 72. Central & South America Melanoma Cancer Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Melanoma Cancer Market Share by Application (2015-2020)
Table 74. AB Sciences Company Details
Table 75. AB Sciences Business Overview
Table 76. AB Sciences Product
Table 77. AB Sciences Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 78. AB Sciences Recent Development
Table 79. Incyte Company Details
Table 80. Incyte Business Overview
Table 81. Incyte Product
Table 82. Incyte Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 83. Incyte Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Product
Table 87. Merck Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 88. Merck Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. Pierre Fabre Company Details
Table 95. Pierre Fabre Business Overview
Table 96. Pierre Fabre Product
Table 97. Pierre Fabre Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 98. Pierre Fabre Recent Development
Table 99. Amgen Company Details
Table 100. Amgen Business Overview
Table 101. Amgen Product
Table 102. Amgen Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 103. Amgen Recent Development
Table 104. AstraZeneca Company Details
Table 105. AstraZeneca Business Overview
Table 106. AstraZeneca Product
Table 107. AstraZeneca Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 108. AstraZeneca Recent Development
Table 109. Bristol-Myers Squibb Business Overview
Table 110. Bristol-Myers Squibb Product
Table 111. Bristol-Myers Squibb Company Details
Table 112. Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 113. Bristol-Myers Squibb Recent Development
Table 114. Daiichi Sankyo Company Details
Table 115. Daiichi Sankyo Business Overview
Table 116. Daiichi Sankyo Product
Table 117. Daiichi Sankyo Revenue in Melanoma Cancer Business (2015-2020) (Million US$)
Table 118. Daiichi Sankyo Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Cancer Market Share by Type: 2020 VS 2026
Figure 2. Non-invasive melanoma Features
Figure 3. Invasive melanoma Features
Figure 4. Global Melanoma Cancer Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Cancer Research Centers Case Studies
Figure 7. Melanoma Cancer Report Years Considered
Figure 8. Global Melanoma Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Melanoma Cancer Market Share by Regions: 2020 VS 2026
Figure 10. Global Melanoma Cancer Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Melanoma Cancer Market Share by Players in 2019
Figure 13. Global Top Melanoma Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Cancer as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Melanoma Cancer Revenue in 2019
Figure 15. North America Melanoma Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Melanoma Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Melanoma Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Melanoma Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Melanoma Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Melanoma Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Melanoma Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
非黒色腫皮膚がんの世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…- 非黒色腫皮膚がん治療の世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 黒色腫の世界市場（～2026年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…
- 悪性黒子型黒色腫治療薬の世界市場（～2026年） Lentigo maligna is a subtype of melanoma in situ that is characterized by an atypical proliferation of melanocytes within the basal epidermis; lentigo maligna that invades the dermis is termed lentigo maligna melanoma. Market Analysis and Insights: Global Lentigo Maligna Melanoma Therapeutic Market …
- 転移性ブドウ膜黒色腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Metastatic Uveal Melanoma Thereapeutics Market The global Metastatic Uveal Melanoma Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metastatic Uveal Melanoma Thereapeu…